AB-1005

DRUG2 trials

Sponsors

AskBio Inc, Bayer

Conditions

PARKINSON DISEASE (Disorder)Parkinson Disease

Phase 2

Prescriptive Infusion Algorithm (PIA)

Not yet recruitingNCT07215403

AskBio IncPARKINSON DISEASE (Disorder)

Start: 2026-11-01End: 2028-11-01Target: 18Updated: 2026-07-27

A Study of AB-1005 Gene Therapy in Japanese Adults With Moderate Parkinson's Disease (J-REGENERATE-PD)

Not yet recruitingNCT07566429

BayerParkinson Disease

Start: 2027-01-25End: 2032-12-15Target: 8Updated: 2026-07-29